Literature DB >> 30195581

Transposons, p53 and Genome Security.

Bhavana Tiwari1, Amanda E Jones1, John M Abrams2.   

Abstract

p53, the most commonly mutated tumor suppressor, is a transcription factor known to regulate proliferation, senescence, and apoptosis. Compelling studies have found that p53 may prevent oncogenesis through effectors that are unrelated to these canonical processes and recent findings have uncovered ancient roles for p53 in the containment of mobile elements. Together, these developments raise the possibility that some p53-driven cancers could result from unrestrained transposons. Here, we explore evidence linking conserved features of p53 biology to the control of transposons. We also show how p53-deficient cells can be exploited to probe the behavior of transposons and illustrate how unrestrained transposons incited by p53 loss might contribute to human malignancies.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  cancer; mobile elements; p53 biology; retrotransposons; transposons; transrepression

Mesh:

Substances:

Year:  2018        PMID: 30195581      PMCID: PMC6260979          DOI: 10.1016/j.tig.2018.08.003

Source DB:  PubMed          Journal:  Trends Genet        ISSN: 0168-9525            Impact factor:   11.639


  87 in total

1.  The p53MH algorithm and its application in detecting p53-responsive genes.

Authors:  J Hoh; S Jin; T Parrado; J Edington; A J Levine; J Ott
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-19       Impact factor: 11.205

2.  Methylation and deamination of CpGs generate p53-binding sites on a genomic scale.

Authors:  Tomasz Zemojtel; Szymon M Kielbasa; Peter F Arndt; Ho-Ryun Chung; Martin Vingron
Journal:  Trends Genet       Date:  2008-12-26       Impact factor: 11.639

3.  Human L1 retrotransposon encodes a conserved endonuclease required for retrotransposition.

Authors:  Q Feng; J V Moran; H H Kazazian; J D Boeke
Journal:  Cell       Date:  1996-11-29       Impact factor: 41.582

4.  p53 is required for female germline stem cell maintenance in P-element hybrid dysgenesis.

Authors:  Sadia Tasnim; Erin S Kelleher
Journal:  Dev Biol       Date:  2017-12-30       Impact factor: 3.582

Review 5.  Mutant p53 gain-of-function in cancer.

Authors:  Moshe Oren; Varda Rotter
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-02       Impact factor: 10.005

6.  Deletion analysis defines distinct functional domains for protein-protein and nucleic acid interactions in the ORF1 protein of mouse LINE-1.

Authors:  S L Martin; J Li; J A Weisz
Journal:  J Mol Biol       Date:  2000-11-17       Impact factor: 5.469

7.  p53 directs focused genomic responses in Drosophila.

Authors:  F Akdemir; A Christich; N Sogame; J Chapo; J M Abrams
Journal:  Oncogene       Date:  2007-02-19       Impact factor: 9.867

8.  Somatic expression of LINE-1 elements in human tissues.

Authors:  Victoria P Belancio; Astrid M Roy-Engel; Radhika R Pochampally; Prescott Deininger
Journal:  Nucleic Acids Res       Date:  2010-03-09       Impact factor: 16.971

9.  Cell context dependent p53 genome-wide binding patterns and enrichment at repeats.

Authors:  Krassimira Botcheva; Sean R McCorkle
Journal:  PLoS One       Date:  2014-11-21       Impact factor: 3.240

Review 10.  The Reverse Transcriptase Encoded by LINE-1 Retrotransposons in the Genesis, Progression, and Therapy of Cancer.

Authors:  Ilaria Sciamanna; Chiara De Luca; Corrado Spadafora
Journal:  Front Chem       Date:  2016-02-11       Impact factor: 5.221

View more
  10 in total

1.  P53: The endothelium defender.

Authors:  Mohammad Afaz Uddin; Nektarios Barabutis
Journal:  J Cell Biochem       Date:  2019-02-28       Impact factor: 4.429

2.  Activating STING1-dependent immune signaling in TP53 mutant and wild-type acute myeloid leukemia.

Authors:  Aksinija A Kogan; Michael J Topper; Anna J Dellomo; Lora Stojanovic; Lena J McLaughlin; T Michael Creed; Christian L Eberly; Tami J Kingsbury; Maria R Baer; Michael D Kessler; Stephen B Baylin; Feyruz V Rassool
Journal:  Proc Natl Acad Sci U S A       Date:  2022-06-27       Impact factor: 12.779

3.  Convergent evolution of a genotoxic stress response in a parasite-specific p53 homolog.

Authors:  George R Wendt; Divya A Shiroor; Carolyn E Adler; James J Collins
Journal:  Proc Natl Acad Sci U S A       Date:  2022-09-06       Impact factor: 12.779

Review 4.  Traditional Chinese medicine as a cancer treatment: Modern perspectives of ancient but advanced science.

Authors:  Yuening Xiang; Zimu Guo; Pengfei Zhu; Jia Chen; Yongye Huang
Journal:  Cancer Med       Date:  2019-04-03       Impact factor: 4.452

5.  LINC01116 promotes the proliferation and invasion of glioma by regulating the microRNA‑744‑5p‑MDM2‑p53 axis.

Authors:  Li Jiang; Chao Cheng; Wei Ji; Hao Wang; Quan Du; Xiaoqiao Dong; Junfei Shao; Wenhua Yu
Journal:  Mol Med Rep       Date:  2021-03-24       Impact factor: 2.952

Review 6.  Cellular Senescence Affects Cardiac Regeneration and Repair in Ischemic Heart Disease.

Authors:  Chi Yan; Zhimeng Xu; Weiqiang Huang
Journal:  Aging Dis       Date:  2021-04-01       Impact factor: 6.745

Review 7.  Reconsidering LINE-1's role in cancer: does LINE-1 function as a reporter detecting early cancer-associated epigenetic signatures?

Authors:  Maxfield M G Kelsey
Journal:  Evol Med Public Health       Date:  2021-02-14

Review 8.  Adaptive homeostasis and the p53 isoform network.

Authors:  Sunali Mehta; Hamish Campbell; Catherine J Drummond; Kunyu Li; Kaisha Murray; Tania Slatter; Jean-Christophe Bourdon; Antony W Braithwaite
Journal:  EMBO Rep       Date:  2021-11-15       Impact factor: 8.807

9.  Olive Oil Improves While Trans Fatty Acids Further Aggravate the Hypomethylation of LINE-1 Retrotransposon DNA in an Environmental Carcinogen Model.

Authors:  Laszlo Szabo; Richard Molnar; Andras Tomesz; Arpad Deutsch; Richard Darago; Timea Varjas; Zsombor Ritter; Jozsef L Szentpeteri; Kitti Andreidesz; Domokos Mathe; Imre Hegedüs; Attila Sik; Ferenc Budan; Istvan Kiss
Journal:  Nutrients       Date:  2022-02-21       Impact factor: 5.717

10.  miR‑378 in combination with ultrasonic irradiation and SonoVue microbubbles transfection inhibits hepatoma cell growth.

Authors:  Jianjun Wang; Yunchun Li; Qianfeng Ma; Jiaxin Huang
Journal:  Mol Med Rep       Date:  2020-03-30       Impact factor: 2.952

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.